| 000 | 00950 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518014437.0 | ||
| 264 | 0 | _c20190827 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.14859 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMansfield, J | |
| 245 | 0 | 0 |
_aEditorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to re-assess? _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _c08 2018 |
||
| 300 |
_a487-488 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aCrohn Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMesalamine |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aMacDougall, L | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 48 _gno. 4 _gp. 487-488 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.14859 _zAvailable from publisher's website |
| 999 |
_c29200982 _d29200982 |
||